BSX

#218
Boston Scientific Corporation Common Stock
48.3 3 USD
-2.21%
Сектор: Здравоохранение
Базовая: USD
Валюта прибыли: USD
Дневной диапазон
48.13
48.63
Годовой диапазон
48.13
109.49
Дневное изменение
-2.21%
Месячное изменение
-15.33%
6-месячное изменение
-52.52%
Годовое изменение
-53.76%
Предыдущее закрытие
49.4 2
Open
48.3 0
Low
48.1 3
High
48.6 3
Volume
11.2 K
Открыть полный график Full chart

Financials

Обзор Отчетность Статистика
Квартал Год
  • Market Capitalization 71.84 B
  • Employee 59 K
  • Founded 1979
  • CEO Michael F. Mahoney
  • Website www.bostonscientific.com
  • Headquarter Delaware, United States
  • FIGI BBG000C0LW92
  • Industry Медицинские приборы
Общий доход
Чистая прибыль
Базовая прибыль на акцию
Общий долг
Свободный денежный поток
Денежные средства и эквиваленты
Коэффициент цена/прибыль
26.26
Коэффициент цена/денежный поток
4.55

Boston Scientific Corporation Common Stock

Boston Scientific Corporation is an American biotechnology and biomedical engineering firm and multinational manufacturer of medical devices used in interventional medical specialties, including interventional radiology, interventional cardiology, peripheral interventions, neuromodulation, neurovascular intervention, electrophysiology, cardiac surgery, vascular surgery, endoscopy, oncology, urology and gynecology. The company is known for the development of the Taxus Stent, a drug-eluting stent which is used to open clogged arteries. The company acquired Cameron Health in June 2012 and began to offer a minimally invasive implantable cardioverter-defibrillator called the EMBLEM subcutaneous implantable defibrillator. Over the last 20 years, Boston Scientific has had some high-profile patent infringement cases. It has made extensive payouts, including $1.725 billion to Johnson & Johnson, $85 million to Nevro and $42 million to TissueGen. BSC is headquartered in Marlborough, Massachusetts and incorporated in Delaware.

Новости